MBHB Partner Kevin Noonan discusses the potential expansion of the proposed BIOSECURE Act

In Fierce Pharma, MBHB Partner Kevin Noonan shares insights into the proposed changes to the BIOSECURE Act and possible implications for the biotech industry. View the article.